PEACE-2 finds adding cabazitaxel to ADT plus radiotherapy fails to improve survival in high-risk localized prostate cancer, while increasing severe toxicities and deaths.
US deploys PrSM in Iran war, marking first combat use; CENTCOM shows HIMARS launch during Operation Epic Fury.
Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results